Seattle Genetics stays step ahead of rivals with bladder cancer data
Bio Pharma Dive
SEPTEMBER 18, 2020
Data confirming the company's drug Padcev can extend the lives of bladder cancer patients should strengthen its position with regulators, although Immunomedics is close behind with a competing treatment.
Let's personalize your content